I did read all of your post pledge. I don't read all of all of your posts.
Hypothetically - if MSB gets a CRL on 7 January - what do you think the price will drop down too?
Is 31 cents too low do you think - a reverse 5 bagger ?
If you knew for a near certainty that MSB was going to get a CRL (right on the pdufa date) would you know how to profit from that? LED I suspect would know the mechanisms - but she is betting the other way.
Its ironic the india or pakistani sounding nick starting with R thinks you are a day trader - when most of the mouthy MSB longs are traders from their own comments.
I see this - post- as related to CYP because I think a converse of pfeifer's argument that a first approval is good for CYP is trie - I see another MSB CRL as not being good for CYP. All the nearology - a rising tide lifts all boards - will think the tide has gone out.
I think there are so many retail holders that are in the clueless believer category that they will think bad news - scary - we must run from this and hide from this and woe is us.
I have found the wayback machine ODAC transcripts. Still online. I don't need them for myself as I still have electonic copied and hardcopies I downloaded.
But I posted a lengthy explanation of why IL2 couldn't be the potency assay its IL2 r alpha - and I confirmed that is what it was both in MSBs ODAC papers and in FDA reply and discussion and then I found that Steve Bauer has largely confirmed (I"d forgotten what he said about other donors being needed) I'm doing my analysis now from an understanding of the science.
I saw the Kilian presentation - he has updated the old slide about the standard or convention way of getting cells to be much the same - but he is now - newly - differently - talking about variable donors.
Its like he is reading what I write. - Who has been talking about the donor exposure (that not having different donors could constitute a weakness in MSBs potency assay validation AND its having an adequate controlled trial more (I know of no-one) ?
- Forums
- ASX - By Stock
- CYP
- Ann: Updated Investor Presentation
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.0¢

Ann: Updated Investor Presentation, page-22
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 16.0¢ | $1.021K | 6.379K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 77738 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 3400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 77738 | 0.160 |
4 | 148709 | 0.155 |
4 | 86673 | 0.150 |
2 | 45000 | 0.140 |
1 | 10937 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 3400 | 1 |
0.170 | 70000 | 2 |
0.175 | 77450 | 2 |
0.180 | 146968 | 5 |
0.185 | 35990 | 1 |
Last trade - 09.59am 24/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |